Quick Takeaways
- SUPN - SUPERNUS PHARMACEUTICALS, INC. has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: -$32,269,469.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 13 Insiders of SUPERNUS PHARMACEUTICALS, INC.
- Symbol
- SUPN on Nasdaq
- Location
- Rockville, MD
What Changed
- Buy value: ; sell value: $32,269,469.
- Net share flow: -682,797.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$32,269,469.
Buys
$0
Shares: 0
Insiders: 0
Sells
$32,269,469
Shares: 682,797
Insiders: 9
Net
-$32,269,469
Shares: -682,797
Insiders: -9
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 181,381 | $0 | $9,225,228 | -$9,225,228 |
| 3-6 | 0 | 20,710 | $0 | $1,039,702 | -$1,039,702 |
| 6-9 | 0 | 480,706 | $0 | $22,004,539 | -$22,004,539 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
SUPERNUS PHARMACEUTICALS, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jack A. Khattar | President, CEO, Director | $113,252,362 | -$20,309,838 | -15% | Mixed | 13 Mar 2026 |
| Charles W. Newhall III | Director | $6,291,759 | -$1,539,270 | -20% | Mixed | 24 Feb 2026 |
| Frederick M. Hudson | Director | $3,235,159 | -$586,858 | -15% | Mixed | 12 Mar 2026 |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | $2,631,048 | Mixed | 23 Feb 2024 | ||
| John M. Siebert | Director | $2,555,624 | Mixed | 23 Feb 2024 | ||
| Georges Gemayel | Director | $1,623,339 | -$1,002,811 | -38% | Mixed | 05 Mar 2026 |
| Carrolee Barlow | Director | $1,509,894 | Mixed | 24 Feb 2026 | ||
| Frank Mottola | SVP, Chief Tech. Ops. Officer | $1,138,181 | -$1,947,714 | -63% | Mixed | 06 Mar 2026 |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | $958,256 | -$5,419,984 | -85% | Mixed | 16 Mar 2026 |
| Jonathan Rubin | SVP, Chief Medical Officer | $774,130 | Mixed | 25 Feb 2026 | ||
| Timothy C. Dec | Senior Vice-President & CFO | $620,801 | -$524,092 | -46% | Mixed | 06 Mar 2026 |
| Bethany Sensenig | Director | $177,658 | -$455,105 | -72% | Mixed | 19 Feb 2026 |
| William Todd Horich | SVP, Commercial Operations | $0 | -$483,797 | -100% | Mixed | 06 Mar 2026 |
Top shareholders of SUPERNUS PHARMACEUTICALS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
15%
from 13D/G
|
8,735,868
|
$434,172,640 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
6,048,496
|
$300,610,252 | — | 31 Dec 2025 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13D/G
|
Vanguard Portfolio Management |
5.7%
|
3,263,309
|
$168,680,442 | $0 | 31 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
5.7%
|
3,281,615
|
$161,652,355 | +$12,092,936 | 11 Feb 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
|
Vanguard Capital Management |
5%
|
2,900,884
|
$149,946,694 | $0 | 31 Mar 2026 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
4.8%
from 13D/G
|
2,764,000
|
$137,370,800 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
2,712,341
|
$134,804,044 | — | 31 Dec 2025 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
4%
|
2,307,639
|
$114,690,000 | — | 31 Dec 2025 | |
| Jack A. Khattar |
3/4/5
|
President, CEO, Director |
—
mixed-class rows
|
2,540,854
mixed-class rows
|
$113,252,362 | -$20,309,838 | 13 Mar 2026 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.9%
|
2,264,800
|
$112,560,560 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
2,219,228
|
$110,295,632 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3%
|
1,732,522
|
$86,106,343 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
1,472,899
|
$73,214,921 | — | 31 Dec 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
2.5%
|
1,448,842
|
$72,007,447 | — | 31 Dec 2025 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
2.4%
|
1,406,522
|
$69,904,143 | — | 31 Dec 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.9%
|
1,080,716
|
$53,712,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
1,079,471
|
$53,649,823 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.2%
|
707,982
|
$35,186,705 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
703,625
|
$34,970,163 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
670,413
|
$33,319,527 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
660,310
|
$32,817,407 | — | 31 Dec 2025 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
612,538
|
$30,443,139 | — | 31 Dec 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.96%
|
553,095
|
$27,488,822 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.91%
|
526,220
|
$26,153,134 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.9%
|
520,747
|
$25,881,103 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.84%
|
483,399
|
$24,760,185 | — | 31 Dec 2025 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.81%
|
467,886
|
$23,253,934 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.79%
|
452,959
|
$22,512,063 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.69%
|
395,761
|
$19,669,322 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.64%
|
370,788
|
$18,428,151 | — | 31 Dec 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.57%
|
326,039
|
$16,204,139 | — | 31 Dec 2025 | |
| Krensavage Asset Management, LLC |
13F
|
Company |
0.54%
|
313,499
|
$15,581,000 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.54%
|
311,838
|
$15,498,349 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.53%
|
306,665
|
$15,225,000 | — | 31 Dec 2025 | |
| SYSTEMATIC FINANCIAL MANAGEMENT LP |
13F
|
Company |
0.53%
|
304,226
|
$15,120,110 | — | 31 Dec 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.53%
|
303,716
|
$15,094,685 | — | 31 Dec 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.47%
|
271,574
|
$13,497,228 | — | 31 Dec 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.45%
|
257,465
|
$12,796,011 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.44%
|
251,756
|
$12,512,275 | — | 31 Dec 2025 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.41%
|
239,183
|
$11,887,395 | — | 31 Dec 2025 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
0.41%
|
234,503
|
$11,654,820 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.4%
|
229,126
|
$11,387,562 | — | 31 Dec 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.34%
|
198,406
|
$9,860,778 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.34%
|
197,737
|
$9,827,529 | — | 31 Dec 2025 | |
| Freestone Grove Partners LP |
13F
|
Company |
0.34%
|
196,318
|
$9,757,005 | — | 31 Dec 2025 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.34%
|
193,572
|
$9,620,528 | — | 31 Dec 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.33%
|
189,942
|
$9,476,206 | — | 31 Dec 2025 | |
| THIRD AVENUE MANAGEMENT LLC |
13F
|
Company |
0.33%
|
189,493
|
$9,417,802 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.32%
|
183,688
|
$9,129,294 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.31%
|
181,027
|
$8,997,061 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for SUPERNUS PHARMACEUTICALS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Padmanabh P. Bhatt | SUPN | Common Stock | Sale | -29.8% | $359,621 | $49.60 | -7,250 | 17,044 | 18 Mar 2026 | Direct |
| Padmanabh P. Bhatt | SUPN | Common Stock | Options Exercise | 42.5% | 7,250 | 24,294 | 18 Mar 2026 | Direct | ||
| Padmanabh P. Bhatt | SUPN | Employee Stock Option (Right to Buy) | Options Exercise | -100% | -7,250 | 0 | 18 Mar 2026 | Direct | ||
| Padmanabh P. Bhatt | SUPN | Common Stock | Sale | -74.6% | $2,514,886 | $50.30 | -50,000 | 17,044 | 17 Mar 2026 | Direct |
| Padmanabh P. Bhatt | SUPN | Common Stock | Options Exercise | 293.4% | 50,000 | 67,044 | 17 Mar 2026 | Direct | ||
| Padmanabh P. Bhatt | SUPN | Employee Stock Option (Right to Buy) | Options Exercise | -100% | -50,000 | 0 | 17 Mar 2026 | Direct | ||
| Padmanabh P. Bhatt | SUPN | Common Stock | Sale | -74.6% | $2,513,925 | $50.28 | -50,000 | 17,044 | 16 Mar 2026 | Direct |
| Padmanabh P. Bhatt | SUPN | Common Stock | Options Exercise | 293.4% | 50,000 | 67,044 | 16 Mar 2026 | Direct | ||
| Padmanabh P. Bhatt | SUPN | Employee Stock Option (Right to Buy) | Options Exercise | -100% | -50,000 | 0 | 16 Mar 2026 | Direct | ||
| Jack A. Khattar | SUPN | Common Stock | Sale | -3.52% | $1,763,124 | $50.38 | -35,000 | 958,100 | 13 Mar 2026 | By the KBT Trust |
| Jack A. Khattar | SUPN | Common Stock | Other | -1.24% | -12,500 | 993,100 | 13 Mar 2026 | By the KBT Trust | ||
| Jack A. Khattar | SUPN | Common Stock | Other | 1.02% | 12,500 | 1,241,144 | 13 Mar 2026 | Direct | ||
| Frederick M. Hudson | SUPN | Common Stock | Sale | -8.16% | $271,725 | $50.61 | -5,369 | 60,413 | 12 Mar 2026 | Direct |
| William Todd Horich | SUPN | Common Stock | Sale | -100% | $244,145 | $55.00 | -4,439 | 0 | 10 Mar 2026 | Direct |
| Frank Mottola | SUPN | Common Stock | Sale | -8.09% | $87,074 | $53.65 | -1,623 | 18,440 | 09 Mar 2026 | Direct |
| William Todd Horich | SUPN | Common Stock | Sale | -50% | $239,652 | $54.00 | -4,438 | 4,439 | 09 Mar 2026 | Direct |
| Jack A. Khattar | SUPN | Common Stock | Tax liability | -1.33% | -16,574 | 1,228,644 | 06 Mar 2026 | Direct | ||
| Jack A. Khattar | SUPN | Common Stock | Options Exercise | 3.2% | 38,640 | 1,245,218 | 06 Mar 2026 | Direct | ||
| Jack A. Khattar | SUPN | Performance Share Unit | Options Exercise | -100% | -38,640 | 0 | 06 Mar 2026 | Direct | ||
| Frank Mottola | SUPN | Common Stock | Tax liability | -8.2% | -1,793 | 20,063 | 06 Mar 2026 | Direct | ||
| Frank Mottola | SUPN | Common Stock | Options Exercise | 20.7% | 3,750 | 21,856 | 06 Mar 2026 | Direct | ||
| Frank Mottola | SUPN | Performance Share Unit | Options Exercise | -100% | -3,750 | 0 | 06 Mar 2026 | Direct | ||
| Timothy C. Dec | SUPN | Common Stock | Tax liability | -30.1% | -2,883 | 6,682 | 06 Mar 2026 | Direct | ||
| Timothy C. Dec | SUPN | Common Stock | Options Exercise | 163% | 6,000 | 9,682 | 06 Mar 2026 | Direct | ||
| Timothy C. Dec | SUPN | Performance Share Unit | Options Exercise | -100% | -6,000 | 0 | 06 Mar 2026 | Direct | ||
| William Todd Horich | SUPN | Common Stock | Tax liability | -35.6% | -3,455 | 6,241 | 06 Mar 2026 | Direct | ||
| William Todd Horich | SUPN | Common Stock | Options Exercise | 301.1% | 7,500 | 9,991 | 06 Mar 2026 | Direct | ||
| William Todd Horich | SUPN | Performance Share Unit | Options Exercise | -100% | -7,500 | 0 | 06 Mar 2026 | Direct | ||
| Georges Gemayel | SUPN | Common Stock | Sale | -24.4% | $465,711 | $53.00 | -8,787 | 27,277 | 06 Mar 2026 | Direct |
| Georges Gemayel | SUPN | Common Stock | Options Exercise | 28.1% | 7,905 | 36,064 | 06 Mar 2026 | Direct | ||
| Georges Gemayel | SUPN | Director Stock Option (Right to Buy) | Options Exercise | -100% | -7,905 | 0 | 06 Mar 2026 | Direct | ||
| Georges Gemayel | SUPN | Common Stock | Sale | -26.2% | $537,100 | $53.71 | -10,000 | 28,159 | 05 Mar 2026 | Direct |
| Jack A. Khattar | SUPN | Performance Share Unit | Award | 38,640 | 38,640 | 28 Feb 2026 | Direct | |||
| Timothy C. Dec | SUPN | Performance Share Unit | Award | 6,000 | 3,000 | 28 Feb 2026 | Direct | |||
| Frank Mottola | SUPN | Performance Share Unit | Award | 3,750 | 3,750 | 28 Feb 2026 | Direct | |||
| Frank Mottola | SUPN | Common Stock | Tax liability | -5.12% | -977 | 18,106 | 25 Feb 2026 | Direct | ||
| Frank Mottola | SUPN | Common Stock | Award | 10.9% | 1,875 | 19,083 | 25 Feb 2026 | Direct | ||
| Frank Mottola | SUPN | Restricted Stock Unit | Disposed to Issuer | -50% | -1,875 | 1,875 | 25 Feb 2026 | Direct | ||
| Timothy C. Dec | SUPN | Common Stock | Tax liability | -20% | -1,279 | 5,115 | 25 Feb 2026 | Direct | ||
| Timothy C. Dec | SUPN | Common Stock | Award | 64.2% | 2,500 | 6,394 | 25 Feb 2026 | Direct | ||
| Timothy C. Dec | SUPN | Restricted Stock Unit | Disposed to Issuer | -50% | -2,500 | 2,500 | 25 Feb 2026 | Direct | ||
| Padmanabh P. Bhatt | SUPN | Common Stock | Tax liability | -3.67% | -650 | 17,044 | 25 Feb 2026 | Direct | ||
| Padmanabh P. Bhatt | SUPN | Common Stock | Award | 7.6% | 1,250 | 17,694 | 25 Feb 2026 | Direct | ||
| Padmanabh P. Bhatt | SUPN | Restricted Stock Unit | Disposed to Issuer | -50% | -1,250 | 1,250 | 25 Feb 2026 | Direct | ||
| Jonathan Rubin | SUPN | Common Stock | Tax liability | -4.82% | -675 | 13,341 | 25 Feb 2026 | Direct | ||
| Jonathan Rubin | SUPN | Common Stock | Award | 9.79% | 1,250 | 14,016 | 25 Feb 2026 | Direct | ||
| Jonathan Rubin | SUPN | Restricted Stock Unit | Disposed to Issuer | -50% | -1,250 | 1,250 | 25 Feb 2026 | Direct | ||
| Timothy C. Dec | SUPN | Common Stock | Tax liability | -52.3% | -2,369 | 2,160 | 24 Feb 2026 | Direct | ||
| Timothy C. Dec | SUPN | Common Stock | Award | 583.2% | 4,625 | 5,418 | 24 Feb 2026 | Direct | ||
| Timothy C. Dec | SUPN | Restricted Stock Unit | Disposed to Issuer | -100% | -4,625 | 0 | 24 Feb 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.